PSAT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.751800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.873400E-01
Normal-vs-Stage2
7.238400E-02
Normal-vs-Stage3
9.751400E-01
Normal-vs-Stage4
6.286000E-01
Stage1-vs-Stage2
4.229200E-01
Stage1-vs-Stage3
7.868400E-01
Stage1-vs-Stage4
9.462600E-01
Stage2-vs-Stage3
6.574200E-01
Stage2-vs-Stage4
4.833800E-01
Stage3-vs-Stage4
7.408000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.110300E-02
Normal-vs-AfricanAmerican
5.323400E-01
Normal-vs-Asian
9.922800E-01
Caucasian-vs-AfricanAmerican
9.145200E-01
Caucasian-vs-Asian
2.057200E-01
AfricanAmerican-vs-Asian
4.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.698000E-02
Normal-vs-Female
2.276600E-01
Male-vs-Female
5.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.771600E-01
Normal-vs-Age(41-60Yrs)
1.077770E-01
Normal-vs-Age(61-80Yrs)
1.178190E-01
Normal-vs-Age(81-100Yrs)
6.889800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.649600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.788200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.987400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.380000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.118600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.302200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.635000E-01
Normal-vs-Daily Drinker
2.154600E-01
Normal-vs-Weekly Drinker
2.630000E-01
Normal-vs-Occasional Drinker
1.650960E-01
Normal-vs-Social Drinker
3.074400E-01
Non Drinker-vs-Daily Drinker
3.586400E-01
Non Drinker-vs-Weekly Drinker
3.817600E-01
Non Drinker-vs-Occasional Drinker
2.762000E-01
Non Drinker-vs-Social Drinker
3.773400E-01
Daily Drinker-vs-Weekly Drinker
8.300000E-01
Daily Drinker-vs-Occasional Drinker
7.566600E-01
Daily Drinker-vs-Social Drinker
6.380800E-01
Weekly Drinker-vs-Occasional Drinker
9.488800E-01
Weekly Drinker-vs-Social Drinker
7.543800E-01
Occasional Drinker-vs-Social Drinker
7.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.768440E-01
Normal-vs-Grade 2
5.502000E-01
Normal-vs-Grade 3
1.379040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.789800E-01
Grade 1-vs-Grade 3
9.181000E-01
Grade 1-vs-Grade 4
1.768440E-01
Grade 2-vs-Grade 3
2.846600E-01
Grade 2-vs-Grade 4
5.502000E-01
Grade 3-vs-Grade 4
1.379040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.662200E-02
Normal-vs-NonDiabetic
3.187800E-01
Diabetic-vs-NonDiabetic
2.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.783800E-01
Normal-vs-NoPancreatitis
1.137160E-01
Pancreatitis-vs-NoPancreatitis
6.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.709200E-01
Normal-vs-N1
4.900100E-02
N0-vs-N1
2.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.955600E-02
Normal-vs-TP53-NonMutant
8.560000E-02
TP53-Mutant-vs-TP53-NonMutant
7.439600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
